bluebird bio, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
bluebird bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • bluebird bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $189M, a 37.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $189M -$114M -37.5% Jun 30, 2024 10-Q 2024-09-27
Q1 2024 $195M -$74.9M -27.7% Mar 31, 2024 10-Q 2024-09-13
Q4 2023 $201M -$29.8M -12.9% Dec 31, 2023 10-Q 2024-09-27
Q3 2023 $295M +$6.03M +2.09% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $303M +$10.1M +3.46% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $270M +$158M +141% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $231M +$139M +152% Dec 31, 2022 10-K 2024-09-13
Q3 2022 $289M +$114M +65.5% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $293M +$102M +53.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $112M -$86.1M -43.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $91.5M +$24M +35.5% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $174M -$14M -7.44% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $191M +$1.53M +0.81% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $198M +$3.5M +1.8% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $67.6M -$118M -63.7% Dec 31, 2020 10-K 2022-03-04
Q3 2020 $188M -$3.11M -1.63% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $189M -$1.52M -0.79% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $194M +$9.85M +5.34% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $186M +$58.6M +46% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $192M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $191M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $185M Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $127M Jan 1, 2019 10-Q 2019-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.